Deepika Pakianathan's Net Worth

$687 Thousand

Estimate Recalculated Nov 7, 2024 12:13PM EST

Who is Deepika Pakianathan?

Deepika Pakianathan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TRANS1 INC, ALDER BIOPHARMACEUTICALS INC, Alexza Pharmaceuticals Inc., TriVascular Technologies, Inc., TANDEM DIABETES CARE INC, Senseonics Holdings, Inc., Theravance Biopharma, Inc., PARDES BIOSCIENCES, INC., Karyopharm Therapeutics Inc., FS Development Corp., Calithera Biosciences, Inc., OncoMed Pharmaceuticals Inc, and Mereo BioPharma Group plc.

SEC CIK

Deepika Pakianathan's CIK is 0001270734

Past Insider Trading and Trends

2024 was Deepika Pakianathan's most active year for acquiring shares with 10 total transactions. Deepika Pakianathan's most active month to acquire stocks was the month of April. 2016 was Deepika Pakianathan's most active year for disposing of shares, totalling 10 transactions. Deepika Pakianathan's most active month to dispose stocks was the month of May. 2024 saw Deepika Pakianathan paying a total of $151,116.34 for 253,357 shares, this is the most they've acquired in one year. In 2024 Deepika Pakianathan cashed out on 278,244 shares for a total of $466,209.87, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALDER BIOPHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 19
Form 4
+36.45%
2.84M
$10.00
$3,500,000.00
10.63M
May 13
Form 4
+36.45%
2.84M
$10.00
$3,500,000.00
10.63M
May 13
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Alexza Pharmaceuticals Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-99.63K
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jul 28
Form 4
-70.69%
-15.88K
—
—
6.59K
Jan 26
Form 4
-37.45%
-13.45K
—
—
22.47K
Jun 4
Form 4
—
0
—
—
0
May 18
Form 4
+111.13%
18.91K
—
—
35.92K
Jan 26
Form 4
—
0
—
—
0
May 7
Form 4
+1,601.40%
16.01K
—
—
17.01K
Jan 22
Form 4
—
0
—
—
0
May 27
Form 4
—
0
—
—
0
May 23
Form 4
∞
989.68K
—
—
989.68K
Mar 13
Form 4
∞
1K
$8.00
$8,000.00
1K
Mar 8
Form 3
—
0
—
—
0
No matching records found

TriVascular Technologies, Inc. No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.54M
—
—
0
Feb 3
Form 4
∞
3.54M
$12.00
$9,999,996.00
3.54M
Nov 1 - Apr 22
Form 3
—
0
—
—
0
No matching records found

TANDEM DIABETES CARE INC (TNDM) Snapshot price: $42.4

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.67M
—
—
3.67M
Nov 19
Form 3
—
0
—
—
0
No matching records found

Senseonics Holdings, Inc. (SENS) Snapshot price: $0.338

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+12.14%
1.23M
$2.85
$3,499,999.50
11.35M
Mar 23
Form 3
—
0
—
—
0
No matching records found